SEC Stock Data Quick Answer Ainos, Inc. reported Cash and Equivalents of $417.4 thousand for fiscal year 2025. Ainos, Inc. Cash and Equivalents — Annual History Fiscal Year Cash and Equivalents YoY Change 2025 $417.4K -89.3% 2024 $3.89M +106.5% 2023 $1.89M +1.7% 2022 $1.85M +5.8% 2021 $1.75M +7773.7% 2020 $22.2K -94.6% 2019 $409.0K -68.0% 2018 $1.28M -37.4% 2017 … Read more
Quick Answer Ainos, Inc. reported Total Assets of $20.87 million for fiscal year 2025. Ainos, Inc. Total Assets — Annual History Fiscal Year Total Assets YoY Change 2025 $20.87M -27.6% 2024 $28.82M -9.5% 2023 $31.84M -14.2% 2022 $37.11M -9.1% 2021 $40.82M +15583.3% 2020 $260.3K -56.4% 2019 $596.6K -59.2% 2018 $1.46M -36.2% 2017 $2.29M +395.8% 2016 … Read more
Quick Answer Ainos, Inc. reported Diluted EPS of $3.46 per share (loss) for fiscal year 2025. Ainos, Inc. Diluted EPS — Annual History Fiscal Year Diluted EPS YoY Change 2025 -$3.46 +55.8% 2024 -$7.82 -132.7% 2023 -$3.36 -33500.0% 2013 -$0.01 +0.0% 2012 -$0.01 +50.0% 2011 -$0.02 — Quarterly Diluted EPS Quarter Ending Diluted EPS YoY … Read more
Quick Answer Ainos, Inc. reported Net Income of -$14.77 million for fiscal year 2025. Ainos, Inc. Net Income — Annual History Fiscal Year Net Income YoY Change 2025 -$14.77M +0.6% 2024 -$14.86M -7.9% 2023 -$13.77M +1.7% 2022 -$14.01M -260.2% 2021 -$3.89M -168.1% 2020 -$1.45M +8.3% 2019 -$1.58M -18.1% 2018 -$1.34M -116.8% 2017 -$617.4K +7.9% 2016 … Read more
Quick Answer Ainos, Inc. reported Total Revenue of $124.2 thousand for fiscal year 2025. Ainos, Inc. Total Revenue — Annual History Fiscal Year Total Revenue YoY Change 2025 $124.2K +499.0% 2024 $20.7K -83.0% 2023 $122.1K -96.5% 2022 $3.52M +492.0% 2021 $594.6K +3489.7% 2020 $16.6K +41.2% 2019 $11.7K -84.9% 2018 $77.7K -69.0% 2017 $250.9K — 2015 … Read more
Quick Answer Ainos, Inc. reported Total Revenue of $124.2 thousand for fiscal year 2025. Ainos, Inc. — Key Financials by Year Metric 2025 2024 2023 2022 2021 2020 Total Revenue $124.2K+499.0% $20.7K-83.0% $122.1K-96.5% $3.52M+492.0% $594.6K+3489.7% $16.6K+41.2% Net Income -$14.77M+0.6% -$14.86M-7.9% -$13.77M+1.7% -$14.01M-260.2% -$3.89M-168.1% -$1.45M+8.3% Diluted EPS -$3.46+55.8% -$7.82-132.7% -$3.36 — — — Total Assets $20.87M-27.6% … Read more
Quick Answer AIM ImmunoTech Inc. reported Shares Outstanding of 3.07 million shares for fiscal year 2025. AIM ImmunoTech Inc. Shares Outstanding — Annual History Fiscal Year Shares Outstanding YoY Change 2025 3.07M +368.5% 2024 655,262 -98.7% 2023 49.10M +2.1% 2022 48.08M +0.2% 2021 47.99M +13.9% 2020 42.15M +305.8% 2019 10.39M +837.8% 2018 1.11M -96.6% 2017 … Read more
Quick Answer AIM ImmunoTech Inc. reported Operating Income of -$11.66 million for fiscal year 2025. AIM ImmunoTech Inc. Operating Income — Annual History Fiscal Year Operating Income YoY Change 2025 -$11.66M +41.0% 2024 -$19.77M +38.0% 2023 -$31.92M -60.2% 2022 -$19.92M -5.8% 2021 -$18.84M -24.3% 2020 -$15.15M -21.8% 2019 -$12.44M -8.2% 2018 -$11.50M -0.7% 2017 -$11.42M … Read more
Quick Answer AIM ImmunoTech Inc. reported R&D Expense of $3.92 million for fiscal year 2025. AIM ImmunoTech Inc. R&D Expense — Annual History Fiscal Year R&D Expense YoY Change 2025 $3.92M -36.7% 2024 $6.20M -43.3% 2023 $10.94M +56.5% 2022 $6.99M -8.9% 2021 $7.67M +34.1% 2020 $5.72M +23.0% 2019 $4.65M -2.7% 2018 $4.78M +16.6% 2017 $4.10M … Read more
Quick Answer AIM ImmunoTech Inc. reported Stockholders Equity of -$9.78 million for fiscal year 2025. AIM ImmunoTech Inc. Stockholders Equity — Annual History Fiscal Year Stockholders Equity YoY Change 2025 -$9.78M -640.0% 2024 -$1.32M -112.9% 2023 $10.23M -73.4% 2022 $38.47M -32.4% 2021 $56.88M -7.2% 2020 $61.29M +356.0% 2019 $13.44M +0.0% 2019 $13.44M +140.9% 2018 $5.58M … Read more